| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656214 | HPB | 2017 | 8 Pages |
Abstract
Adjuvant chemotherapy was associated with an OS benefit for patients with stage I PDAC; adjuvant chemoradiation was either of no benefit or associated with worse OS.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Katherine T. Ostapoff, Emmanuel Gabriel, Kristopher Attwood, Boris W. Kuvshinoff, Steven J. Nurkin, Steven N. Hochwald,